drugset / Trial / NCT00395694
Clinical Evaluation of BW430C in Epilepsy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate safety information of BW430C when administered using the lower starting doses and slower dose escalations as recommended Global Data Sheet
Timeline
- Start
- 2006-08-07
- Primary completion
- 2009-03-01
- Completion
- 2009-03-26
Publications
- Background Shunsuke Ohtahara, Tateki Fujiwara, Sunao Kaneko, Masafumi Iijima. Clinical Evaluation of Lamotrigine with the Current Recommended Dose in Overseas - Phase III study of lamotrigine in patients with epilepsy treated with valproate - . [J.New Rem. & Clin. Vol.57 No.9 2008]. 2008;57(J.New Rem. & Clin):1442-1453.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamotrigine | Small molecule | — | — |